Everything NWBO is a slow walk - took over 12 years to do a 5 year trial, took ~2 years to spin the whole trial design and report a new topline (after the original primary endpoint failed), and another almost 2 years to file an application for commercial approval (after FDA Type B meeting told them don't bother filing in the U.S.). And now look how long the review process has been -- only explainable if they had multiple RFIs with the usual slow NWBO turnaround.
And also another trait of NWBO's bad management -- poor communication. They even have converted the company to being a contract manufacturer now to line the CEO pockets. Can't make this stuff up.
Market Data 
Markets 
AI
